13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001469336
Total reported value
$86.5M
$86.5M
32 檔
77.8%
The Q1 2026 SEC filing reveals that Empery Asset Management, LP held a total portfolio value of $86.5M, covering 32 public equity positions.
Empery Asset Management, LP executed strategic sector rebalancing during Q1 2026, establishing 13 new positions while fully exiting 12 holdings and trimming 7 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XFOR | X4 Pharmaceuticals Inc | Stock-Other | 44.50% | -7.07% | -0.08% | |
| 2 | EMPD | Empery Digital Inc | Stock-Other | 14.93% | -2.87% | — | |
| 3 | DTIL | Precision Biosciences Inc | Stock-Other | 13.04% | -5.99% | -10.29% | |
| 4 | ✓ | Imperial Pete Inc | Stock-Other | 4.52% | -4.52% | EXIT | |
| 5 | VENU | Venu Holding CORP | Stock-Other | 4.02% | -2.67% | — | |
| 6 | TNYA | Tenaya Therapeutics Inc | Stock-Other | 3.58% | -0.28% | -20.82% | |
| 7 | BSIN | Big Sky Industrial Inc | Stock-Other | 2.04% | -2.04% | EXIT | |
| 8 | SCYXEUR | Scynexis Inc | Stock-Other | 2.04% | -2.04% | EXIT | |
| 9 | CYN | Cyngn Inc | Stock-Other | 1.92% | -0.43% | — | |
| 10 | JAGU | Jaguar Uranium Corp-cl A | Stock-Other | 1.61% | -0.67% | — | |
| 11 | MSLE | Satellos Bioscience Inc | Stock-Other | 1.56% | -0.60% | — | |
| 12 | ✓ | Critical Metals CORP | Stock-Other | 1.26% | -1.26% | EXIT | |
| 13 | URG | Ur-energy Inc | Stock-Other | 1.11% | -0.13% | — | |
| 14 | PMN | Promis Neurosciences Inc | Stock-Other | 0.92% | -0.92% | EXIT | |
| 15 | SLE | Super League Enterprise Inc | Stock-Other | 0.59% | -0.59% | EXIT | |
| 16 | TLPH | Talphera Inc | Stock-Other | 0.53% | -0.53% | EXIT | |
| 17 | BNTC | Benitec Biopharma Inc | Stock-Other | 0.39% | -0.39% | EXIT | |
| 18 | BCTXL | Briacell Therapeutics CORP | Stock-Other | 0.37% | -0.06% | — | |
| 19 | ✓ | Abits Group Inc | Stock-Other | 0.32% | -0.32% | EXIT | |
| 20 | ✓ | Parazero Technologies LTD | Stock-Other | 0.26% | -0.20% | — | |
| 21 | ✓ | Nasus Pharma LTD | Stock-Other | 0.12% | -0.12% | EXIT | |
| 22 | BCTXZ | Briacell Therapeutics - 30 | Stock-Other | 0.11% | -0.11% | EXIT | |
| 23 | NTRBW | Nutriband Inc -cw26 | Stock-Other | 0.05% | — | — | |
| 24 | ✓ | Maris Tech LTD | Stock-Other | 0.05% | +0.02% | — | |
| 25 | ✓ | Renatus Tactical Acquis | Stock-Other | 0.03% | +0.01% | — | |
| 26 | ✓ | Neurosense Therapeutics LTD | Stock-Other | 0.02% | -0.01% | — | |
| 27 | MDAIW | Spectral Ai -cw27 | Stock-Other | 0.02% | — | — | |
| 28 | BNCWW | Cea Industries Inc -cw27 | Stock-Other | 0.02% | -0.01% | — | |
| 29 | MDCXW | Medicus Pharma LTD -29 | Stock-Other | 0.01% | -0.01% | EXIT | |
| 30 | ✓ | Jeffs Brands LTD | Stock-Other | 0.01% | — | — | |
| 31 | NXGLW | Nexgel Inc -cw26 | Stock-Other | 0.01% | -0.01% | — | |
| 32 | ✓ | Fgi Industries LTD | Stock-Other | — | +0.01% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | XFOR | X4 Pharmaceuticals Inc | +12.9% | -0.08% | Trim |
| 2 | DTIL | Precision Biosciences Inc | +5% | -10.29% | Trim |
| 3 | EMPD | Empery Digital Inc | +3.1% | — | Unchanged |
| 4 | TNYA | Tenaya Therapeutics Inc | +0.2% | -20.82% | Trim |
| 5 | ✓ | Maris Tech LTD | 0% | — | Unchanged |
| 6 | MDAIW | Spectral Ai -cw27 | 0% | — | Unchanged |
| 7 | ✓ | Jeffs Brands LTD | 0% | — | Unchanged |
| 8 | BNCWW | Cea Industries Inc -cw27 | — | — | Unchanged |
| 9 | MDCXW | Medicus Pharma LTD -29 | — | — | Unchanged |
| 10 | ✓ | Fgi Industries LTD | — | — | Unchanged |
| 11 | NTRBW | Nutriband Inc -cw26 | 0% | — | Unchanged |
| 12 | ✓ | Renatus Tactical Acquis | 0% | — | Unchanged |
| 13 | NXGLW | Nexgel Inc -cw26 | 0% | — | Unchanged |
| 14 | ✓ | Neurosense Therapeutics LTD | 0% | — | Unchanged |
| 15 | BCTXZ | Briacell Therapeutics - 30 | -0.1% | — | Unchanged |
| 16 | BNTC | Benitec Biopharma Inc | -0.3% | -45.09% | Trim |
| 17 | TLPH | Talphera Inc | -0.8% | -55.72% | Trim |
| 18 | ✓ | Critical Metals CORP | -1.8% | -73.13% | Trim |
| 19 | ✓ | Imperial Pete Inc | -5.6% | -72.43% | Trim |
| 20 | IMRX | Immuneering CORP - Class A | — | EXIT | Sold out |
| 21 | ADUR | Aduro Clean Technologies Inc | — | EXIT | Sold out |
| 22 | VENU | Venu Holding CORP | — | NEW | New buy |
| 23 | EOSE | Eos Energy Enterprises Inc | — | EXIT | Sold out |
| 24 | SRZN | Surrozen Inc | — | EXIT | Sold out |
| 25 | BSIN | Big Sky Industrial Inc | — | NEW | New buy |
| 26 | SCYXEUR | Scynexis Inc | — | NEW | New buy |
| 27 | CYN | Cyngn Inc | — | NEW | New buy |
| 28 | JAGU | Jaguar Uranium Corp-cl A | — | NEW | New buy |
| 29 | MSLE | Satellos Bioscience Inc | — | NEW | New buy |
| 30 | KZIA | Kazia Therapeutics-spon Adr | — | EXIT | Sold out |
| 31 | PROF | Profound Medical CORP | — | EXIT | Sold out |
| 32 | URG | Ur-energy Inc | — | NEW | New buy |
| 33 | ✓ | — | EXIT | Sold out | |
| 34 | PMN | Promis Neurosciences Inc | — | NEW | New buy |
| 35 | ✓ | Super League Enterprise Inc | — | EXIT | Sold out |
| 36 | ✓ | Xilio Therapeutics Inc | — | EXIT | Sold out |
| 37 | SLE | Super League Enterprise Inc | — | NEW | New buy |
| 38 | BCTXL | Briacell Therapeutics CORP | — | NEW | New buy |
| 39 | ✓ | Abits Group Inc | — | NEW | New buy |
| 40 | ✓ | Parazero Technologies LTD | — | NEW | New buy |
| 41 | ✓ | Nasus Pharma LTD | — | NEW | New buy |
| 42 | ✓ | Allurion Technologies Inc | — | EXIT | Sold out |
| 43 | TARA | Protara Therapeutic Inc | — | EXIT | Sold out |
| 44 | PCTTW | Purecycle Techno-cw26 | — | EXIT | Sold out |
According to official SEC Form 13F filings, Empery Asset Management, LP reported a total U.S. public equity portfolio value of $86.5M across 32 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including XFOR, EMPD, DTIL) accounted for 77.8% of total reported equity market value during Q1 2026.
Top New Position Initiated
VENU
市值: $3.3M
Top Position Liquidated / Trimmed
IMRX
前期市值: $17.6M
During Q1 2026, Empery Asset Management, LP's top holdings by market value included XFOR (44.5%)、EMPD (14.9%)、DTIL (13.0%). The largest single position, XFOR, represented 44.5% of total portfolio value.
In Q1 2026, Empery Asset Management, LP made 32 total portfolio adjustments, initiating 13 new buys, adding to 0 positions, trimming 7 holdings, and fully liquidating 12 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.